Lentiviral Vectors Market Size, Share, and Growth Forecast, 2026 - 2033

Lentiviral Vectors Market By Product (Third-Generation SIN Vectors, First-Generation Vectors, Others), Component (Upstream Vector Production, Downstream Purification, Others), Application, End-user, and Regional Analysis for 2026 - 2033

ID: PMRREP33074| 191 Pages | 27 Nov 2025 | Format: PDF, Excel, PPT* | Healthcare

Market Growth and Regional Outlook Report by Persistence Market Research

Table of Content

  1. Executive Summary
    1. Global Lentiviral Vectors Market Snapshot, 2026 and 2033
    2. Market Opportunity Assessment, 2026 - 2033, US$ Bn
    3. Key Market Trends
    4. Future Market Projections
    5. Premium Market Insights
    6. Industry Developments and Key Market Events
    7. PMR Analysis and Recommendations
  2. Market Overview
    1. Market Scope and Definition
    2. Market Dynamics
      1. Drivers
      2. Restraints
      3. Opportunity
      4. Key Trends
    3. Macro-economic Factors
      1. Global Sectoral Outlook
      2. Global GDP Growth Outlook
    4. COVID-19 Impact Analysis
    5. Forecast Factors - Relevance and Impact
  3. Value Added Insights
    1. Tool Adoption Analysis
    2. Regulatory Landscape
    3. Value Chain Analysis
    4. PESTLE Analysis
    5. Porter’s Five Force Analysis
  4. Price Analysis, 2025A
    1. Key Highlights
    2. Key Factors Impacting Deployment Costs
    3. Pricing Analysis, By Component Type
  5. Global Lentiviral Vectors Market Outlook
    1. Key Highlights
      1. Market Volume (Units) Projections
      2. Market Size (US$ Bn) and Y-o-Y Growth
      3. Absolute $ Opportunity
    2. Market Size (US$ Bn) and Volume (Units) Analysis and Forecast
      1. Historical Market Size (US$ Bn) Analysis, 2020-2025
      2. Market Size (US$ Bn) Analysis and Forecast, 2026 - 2033
    3. Global Lentiviral Vectors Market Outlook: Product
      1. Introduction / Key Findings
      2. Historical Market Size (US$ Bn) and Volume (Units) Analysis, By Product, 2020 - 2025
      3. Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Product, 2026 - 2033
        1. Third-Generation SIN Vectors
        2. First-Generation Vectors
        3. Second-Generation Vectors
        4. Stable Producer Cell Lines
        5. Suspension & Perfusion-Based LV Production Platforms
      4. Market Attractiveness Analysis: Product
    4. Global Lentiviral Vectors Market Outlook: Component
      1. Introduction / Key Findings
      2. Historical Market Size (US$ Bn) Analysis, By Component, 2020 - 2025
      3. Market Size (US$ Bn) Analysis and Forecast, By Component, 2026 - 2033
        1. Upstream Vector Production
        2. Downstream Purification
        3. Analytical & Quality Control
        4. Plasmid Supply
        5. Fill-Finish & Final Formulation
      4. Market Attractiveness Analysis: Component
    5. Global Lentiviral Vectors Market Outlook: Application
      1. Introduction / Key Findings
      2. Historical Market Size (US$ Bn) Analysis, By Application, 2020 - 2025
      3. Market Size (US$ Bn) Analysis and Forecast, By Application, 2026 - 2033
        1. Ex-Vivo Cell Therapies
        2. In-Vivo Gene Therapies
        3. Research & Preclinical Vector Supply
        4. Vaccination & Immunotherapy Applications
      4. Market Attractiveness Analysis: Application
    6. Global Lentiviral Vectors Market Outlook: End-user
      1. Introduction / Key Findings
      2. Historical Market Size (US$ Bn) Analysis, By End-user, 2020 - 2025
      3. Market Size (US$ Bn) Analysis and Forecast, By End-user, 2026 - 2033
        1. Pharmaceutical & Biotechnology Companies
        2. CDMOs
        3. Academic & Research Institutions
        4. CROs
      4. Market Attractiveness Analysis: End-user
  6. Global Lentiviral Vectors Market Outlook: Region
    1. Key Highlights
    2. Historical Market Size (US$ Bn) and Volume (Units) Analysis, By Region, 2020 - 2025
    3. Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Region, 2026 - 2033
      1. North America
      2. Europe
      3. East Asia
      4. South Asia and Oceania
      5. Latin America
      6. Middle East & Africa
    4. Market Attractiveness Analysis: Region
  7. North America Lentiviral Vectors Market Outlook
    1. Key Highlights
    2. Historical Market Size (US$ Bn) Analysis, By Market, 2020 - 2025
      1. By Country
      2. By Product
      3. By Component
      4. By Application
      5. By End-user
    3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2026 - 2033
      1. U.S.
      2. Canada
    4. Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Product, 2026 - 2033
      1. Third-Generation SIN Vectors
      2. First-Generation Vectors
      3. Second-Generation Vectors
      4. Stable Producer Cell Lines
      5. Suspension & Perfusion-Based LV Production Platforms
    5. Market Size (US$ Bn) Analysis and Forecast, By Component, 2026 - 2033
      1. Upstream Vector Production
      2. Downstream Purification
      3. Analytical & Quality Control
      4. Plasmid Supply
      5. Fill-Finish & Final Formulation
    6. Market Size (US$ Bn) Analysis and Forecast, By Application, 2026 - 2033
      1. Ex-Vivo Cell Therapies
      2. In-Vivo Gene Therapies
      3. Research & Preclinical Vector Supply
      4. Vaccination & Immunotherapy Applications
    7. Market Size (US$ Bn) Analysis and Forecast, By End-user, 2026 - 2033
      1. Pharmaceutical & Biotechnology Companies
      2. CDMOs
      3. Academic & Research Institutions
      4. CROs
    8. Market Attractiveness Analysis
  8. Europe Lentiviral Vectors Market Outlook
    1. Key Highlights
    2. Historical Market Size (US$ Bn) Analysis, By Market, 2020 - 2025
      1. By Country
      2. By Product
      3. By Component
      4. By Application
      5. By End-user
    3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2026 - 2033
      1. Germany
      2. France
      3. U.K.
      4. Italy
      5. Spain
      6. Russia
      7. Türkiye
      8. Rest of Europe
    4. Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Product, 2026 - 2033
      1. Third-Generation SIN Vectors
      2. First-Generation Vectors
      3. Second-Generation Vectors
      4. Stable Producer Cell Lines
      5. Suspension & Perfusion-Based LV Production Platforms
    5. Market Size (US$ Bn) Analysis and Forecast, By Component, 2026 - 2033
      1. Upstream Vector Production
      2. Downstream Purification
      3. Analytical & Quality Control
      4. Plasmid Supply
      5. Fill-Finish & Final Formulation
    6. Market Size (US$ Bn) Analysis and Forecast, By Application, 2026 - 2033
      1. Ex-Vivo Cell Therapies
      2. In-Vivo Gene Therapies
      3. Research & Preclinical Vector Supply
      4. Vaccination & Immunotherapy Applications
    7. Market Size (US$ Bn) Analysis and Forecast, By End-user, 2026 - 2033
      1. Pharmaceutical & Biotechnology Companies
      2. CDMOs
      3. Academic & Research Institutions
      4. CROs
    8. Market Attractiveness Analysis
  9. East Asia Lentiviral Vectors Market Outlook
    1. Key Highlights
    2. Historical Market Size (US$ Bn) Analysis, By Market, 2020 - 2025
      1. By Country
      2. By Product
      3. By Component
      4. By Application
      5. By End-user
    3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2026 - 2033
      1. China
      2. Japan
      3. South Korea
    4. Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Product, 2026 - 2033
      1. Third-Generation SIN Vectors
      2. First-Generation Vectors
      3. Second-Generation Vectors
      4. Stable Producer Cell Lines
      5. Suspension & Perfusion-Based LV Production Platforms
    5. Market Size (US$ Bn) Analysis and Forecast, By Component, 2026 - 2033
      1. Upstream Vector Production
      2. Downstream Purification
      3. Analytical & Quality Control
      4. Plasmid Supply
      5. Fill-Finish & Final Formulation
    6. Market Size (US$ Bn) Analysis and Forecast, By Application, 2026 - 2033
      1. Ex-Vivo Cell Therapies
      2. In-Vivo Gene Therapies
      3. Research & Preclinical Vector Supply
      4. Vaccination & Immunotherapy Applications
    7. Market Size (US$ Bn) Analysis and Forecast, By End-user, 2026 - 2033
      1. Pharmaceutical & Biotechnology Companies
      2. CDMOs
      3. Academic & Research Institutions
      4. CROs
    8. Market Attractiveness Analysis
  10. South Asia & Oceania Lentiviral Vectors Market Outlook
    1. Key Highlights
    2. Historical Market Size (US$ Bn) Analysis, By Market, 2020 - 2025
      1. By Country
      2. By Product
      3. By Component
      4. By Application
      5. By End-user
    3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2026 - 2033
      1. India
      2. Southeast Asia
      3. ANZ
      4. Rest of South Asia & Oceania
    4. Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Product, 2026 - 2033
      1. Third-Generation SIN Vectors
      2. First-Generation Vectors
      3. Second-Generation Vectors
      4. Stable Producer Cell Lines
      5. Suspension & Perfusion-Based LV Production Platforms
    5. Market Size (US$ Bn) Analysis and Forecast, By Component, 2026 - 2033
      1. Upstream Vector Production
      2. Downstream Purification
      3. Analytical & Quality Control
      4. Plasmid Supply
      5. Fill-Finish & Final Formulation
    6. Market Size (US$ Bn) Analysis and Forecast, By Application, 2026 - 2033
      1. Ex-Vivo Cell Therapies
      2. In-Vivo Gene Therapies
      3. Research & Preclinical Vector Supply
      4. Vaccination & Immunotherapy Applications
    7. Market Size (US$ Bn) Analysis and Forecast, By End-user, 2026 - 2033
      1. Pharmaceutical & Biotechnology Companies
      2. CDMOs
      3. Academic & Research Institutions
      4. CROs
    8. Market Attractiveness Analysis
  11. Latin America Lentiviral Vectors Market Outlook
    1. Key Highlights
    2. Historical Market Size (US$ Bn) Analysis, By Market, 2020 - 2025
      1. By Country
      2. By Product
      3. By Component
      4. By Application
      5. By End-user
    3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2026 - 2033
      1. Brazil
      2. Mexico
      3. Rest of Latin America
    4. Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Product, 2026 - 2033
      1. Third-Generation SIN Vectors
      2. First-Generation Vectors
      3. Second-Generation Vectors
      4. Stable Producer Cell Lines
      5. Suspension & Perfusion-Based LV Production Platforms
    5. Market Size (US$ Bn) Analysis and Forecast, By Component, 2026 - 2033
      1. Upstream Vector Production
      2. Downstream Purification
      3. Analytical & Quality Control
      4. Plasmid Supply
      5. Fill-Finish & Final Formulation
    6. Market Size (US$ Bn) Analysis and Forecast, By Application, 2026 - 2033
      1. Ex-Vivo Cell Therapies
      2. In-Vivo Gene Therapies
      3. Research & Preclinical Vector Supply
      4. Vaccination & Immunotherapy Applications
    7. Market Size (US$ Bn) Analysis and Forecast, By End-user, 2026 - 2033
      1. Pharmaceutical & Biotechnology Companies
      2. CDMOs
      3. Academic & Research Institutions
      4. CROs
    8. Market Attractiveness Analysis
  12. Middle East & Africa Lentiviral Vectors Market Outlook
    1. Key Highlights
    2. Historical Market Size (US$ Bn) Analysis, By Market, 2020 - 2025
      1. By Country
      2. By Product
      3. By Component
      4. By Application
      5. By End-user
    3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2026 - 2033
      1. GCC Countries
      2. Egypt
      3. South Africa
      4. Northern Africa
      5. Rest of Middle East & Africa
    4. Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Product, 2026 - 2033
      1. Third-Generation SIN Vectors
      2. First-Generation Vectors
      3. Second-Generation Vectors
      4. Stable Producer Cell Lines
      5. Suspension & Perfusion-Based LV Production Platforms
    5. Market Size (US$ Bn) Analysis and Forecast, By Component, 2026 - 2033
      1. Upstream Vector Production
      2. Downstream Purification
      3. Analytical & Quality Control
      4. Plasmid Supply
      5. Fill-Finish & Final Formulation
    6. Market Size (US$ Bn) Analysis and Forecast, By Application, 2026 - 2033
      1. Ex-Vivo Cell Therapies
      2. In-Vivo Gene Therapies
      3. Research & Preclinical Vector Supply
      4. Vaccination & Immunotherapy Applications
    7. Market Size (US$ Bn) Analysis and Forecast, By End-user, 2026 - 2033
      1. Pharmaceutical & Biotechnology Companies
      2. CDMOs
      3. Academic & Research Institutions
      4. CROs
    8. Market Attractiveness Analysis
  13. Competition Landscape
    1. Market Share Analysis, 2025
    2. Market Structure
      1. Competition Intensity Mapping By Market
      2. Competition Dashboard
    3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
      1. Thermo Fisher Scientific
        1. Overview
        2. Segments and Products
        3. Key Financials
        4. Market Developments
        5. Market Strategy
      2. Oxford Biomedica
      3. Merck KGaA (MilliporeSigma)
      4. Charles River Laboratories
      5. Lonza Group
      6. VGXI
      7. WuXi AppTec
      8. WuXi Biologics
      9. Catalent Biologics
      10. VectorBuilder
      11. FinVector
      12. Sirion Biotech
      13. Cobra Biologics
      14. Takara Bio
      15. Sartorius
      16. Cytiva
      17. Brammer Bio
      18. BlueBird Bio (Vector Core)
      19. OriGene Technologies
      20. Sino Biological
  14. Appendix
    1. Research Methodology
    2. Research Assumptions
    3. Acronyms and Abbreviations
We use cookies to improve user experience.
Google translate